Sonoma pharmaceuticals and microsafe group dmcc announce epa approval for nanocyn® hospital-grade disinfectant in the u.s.

Woodstock, ga.--(business wire)--sonoma pharmaceuticals, inc. (nasdaq: snoa), a global healthcare leader developing and producing patented microcyn® technology-based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions and disinfectant use, and its partner, the microsafe group dmcc, received epa approval for nanocyn® as a hospital-grade disinfectant in the united states. nanocyn®, which is manufacture
SNOA Ratings Summary
SNOA Quant Ranking